The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Influenza Drugs and Vaccines-Global Market Insights and Sales Trends 2025

Influenza Drugs and Vaccines-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1812961

No of Pages : 123

Ask Your Query
Synopsis
The global Influenza Drugs and Vaccines market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Influenza Drugs and Vaccines in various end use industries. The expanding demands from the Hospital Pharmacy, Retail Pharmacy and Online Pharmacy,, are propelling Influenza Drugs and Vaccines market. Influenza Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Influenza Vaccines segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Influenza Drugs and Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Influenza Drugs and Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Influenza Drugs and Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Influenza Drugs and Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Influenza Drugs and Vaccines covered in this report include CSL, Bristol Myers Squibb, AstraZeneca, Eli Lilly, Roche, GlaxoSmithKline, Novartis, Pfizer and Sanofi, etc.
The global Influenza Drugs and Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
CSL
Bristol Myers Squibb
AstraZeneca
Eli Lilly
Roche
GlaxoSmithKline
Novartis
Pfizer
Sanofi
Bayer
Celgene
Seqirus
Protein Sciences Corporation
Serum Institute of India
Emergent Biosolutions
BioCryst Pharmaceuticals
Alvogen
Viatris
Hulan Bio
Changchun Institute of Biological
Jiangsu GDK
Sinovac
Beike Bio
Global Influenza Drugs and Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Influenza Drugs and Vaccines market, Segment by Type:
Influenza Drugs
Influenza Vaccines
Global Influenza Drugs and Vaccines market, by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Influenza Drugs and Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Influenza Drugs and Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Influenza Drugs and Vaccines Market Overview
1.1 Influenza Drugs and Vaccines Product Overview
1.2 Influenza Drugs and Vaccines Market Segment by Type
1.2.1 Influenza Drugs
1.2.2 Influenza Vaccines
1.3 Global Influenza Drugs and Vaccines Market Size by Type
1.3.1 Global Influenza Drugs and Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Influenza Drugs and Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global Influenza Drugs and Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Influenza Drugs and Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe Influenza Drugs and Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Influenza Drugs and Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Influenza Drugs and Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Influenza Drugs and Vaccines Sales Breakdown by Type (2018-2023)
2 Global Influenza Drugs and Vaccines Market Competition by Company
2.1 Global Top Players by Influenza Drugs and Vaccines Sales (2018-2023)
2.2 Global Top Players by Influenza Drugs and Vaccines Revenue (2018-2023)
2.3 Global Top Players by Influenza Drugs and Vaccines Price (2018-2023)
2.4 Global Top Manufacturers Influenza Drugs and Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Influenza Drugs and Vaccines Market Competitive Situation and Trends
2.5.1 Influenza Drugs and Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Influenza Drugs and Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza Drugs and Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Influenza Drugs and Vaccines Market
2.8 Key Manufacturers Influenza Drugs and Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Influenza Drugs and Vaccines Status and Outlook by Region
3.1 Global Influenza Drugs and Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Influenza Drugs and Vaccines Historic Market Size by Region
3.2.1 Global Influenza Drugs and Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global Influenza Drugs and Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global Influenza Drugs and Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Influenza Drugs and Vaccines Forecasted Market Size by Region
3.3.1 Global Influenza Drugs and Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Influenza Drugs and Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Influenza Drugs and Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Influenza Drugs and Vaccines by Application
4.1 Influenza Drugs and Vaccines Market Segment by Application
4.1.1 Hospital Pharmacy
4.1.2 Retail Pharmacy
4.1.3 Online Pharmacy
4.2 Global Influenza Drugs and Vaccines Market Size by Application
4.2.1 Global Influenza Drugs and Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Influenza Drugs and Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global Influenza Drugs and Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Influenza Drugs and Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe Influenza Drugs and Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Influenza Drugs and Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Influenza Drugs and Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Influenza Drugs and Vaccines Sales Breakdown by Application (2018-2023)
5 North America Influenza Drugs and Vaccines by Country
5.1 North America Influenza Drugs and Vaccines Historic Market Size by Country
5.1.1 North America Influenza Drugs and Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Influenza Drugs and Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America Influenza Drugs and Vaccines Sales in Value by Country (2018-2023)
5.2 North America Influenza Drugs and Vaccines Forecasted Market Size by Country
5.2.1 North America Influenza Drugs and Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Influenza Drugs and Vaccines Sales in Value by Country (2024-2029)
6 Europe Influenza Drugs and Vaccines by Country
6.1 Europe Influenza Drugs and Vaccines Historic Market Size by Country
6.1.1 Europe Influenza Drugs and Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Influenza Drugs and Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe Influenza Drugs and Vaccines Sales in Value by Country (2018-2023)
6.2 Europe Influenza Drugs and Vaccines Forecasted Market Size by Country
6.2.1 Europe Influenza Drugs and Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Influenza Drugs and Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Influenza Drugs and Vaccines by Region
7.1 Asia-Pacific Influenza Drugs and Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Influenza Drugs and Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Influenza Drugs and Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Influenza Drugs and Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Influenza Drugs and Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Influenza Drugs and Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Influenza Drugs and Vaccines Sales in Value by Region (2024-2029)
8 Latin America Influenza Drugs and Vaccines by Country
8.1 Latin America Influenza Drugs and Vaccines Historic Market Size by Country
8.1.1 Latin America Influenza Drugs and Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Influenza Drugs and Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America Influenza Drugs and Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America Influenza Drugs and Vaccines Forecasted Market Size by Country
8.2.1 Latin America Influenza Drugs and Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Influenza Drugs and Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Influenza Drugs and Vaccines by Country
9.1 Middle East and Africa Influenza Drugs and Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Influenza Drugs and Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Influenza Drugs and Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Influenza Drugs and Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Influenza Drugs and Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Influenza Drugs and Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Influenza Drugs and Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 CSL
10.1.1 CSL Company Information
10.1.2 CSL Introduction and Business Overview
10.1.3 CSL Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 CSL Influenza Drugs and Vaccines Products Offered
10.1.5 CSL Recent Development
10.2 Bristol Myers Squibb
10.2.1 Bristol Myers Squibb Company Information
10.2.2 Bristol Myers Squibb Introduction and Business Overview
10.2.3 Bristol Myers Squibb Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Bristol Myers Squibb Influenza Drugs and Vaccines Products Offered
10.2.5 Bristol Myers Squibb Recent Development
10.3 AstraZeneca
10.3.1 AstraZeneca Company Information
10.3.2 AstraZeneca Introduction and Business Overview
10.3.3 AstraZeneca Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 AstraZeneca Influenza Drugs and Vaccines Products Offered
10.3.5 AstraZeneca Recent Development
10.4 Eli Lilly
10.4.1 Eli Lilly Company Information
10.4.2 Eli Lilly Introduction and Business Overview
10.4.3 Eli Lilly Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Eli Lilly Influenza Drugs and Vaccines Products Offered
10.4.5 Eli Lilly Recent Development
10.5 Roche
10.5.1 Roche Company Information
10.5.2 Roche Introduction and Business Overview
10.5.3 Roche Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Roche Influenza Drugs and Vaccines Products Offered
10.5.5 Roche Recent Development
10.6 GlaxoSmithKline
10.6.1 GlaxoSmithKline Company Information
10.6.2 GlaxoSmithKline Introduction and Business Overview
10.6.3 GlaxoSmithKline Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 GlaxoSmithKline Influenza Drugs and Vaccines Products Offered
10.6.5 GlaxoSmithKline Recent Development
10.7 Novartis
10.7.1 Novartis Company Information
10.7.2 Novartis Introduction and Business Overview
10.7.3 Novartis Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Novartis Influenza Drugs and Vaccines Products Offered
10.7.5 Novartis Recent Development
10.8 Pfizer
10.8.1 Pfizer Company Information
10.8.2 Pfizer Introduction and Business Overview
10.8.3 Pfizer Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Pfizer Influenza Drugs and Vaccines Products Offered
10.8.5 Pfizer Recent Development
10.9 Sanofi
10.9.1 Sanofi Company Information
10.9.2 Sanofi Introduction and Business Overview
10.9.3 Sanofi Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Sanofi Influenza Drugs and Vaccines Products Offered
10.9.5 Sanofi Recent Development
10.10 Bayer
10.10.1 Bayer Company Information
10.10.2 Bayer Introduction and Business Overview
10.10.3 Bayer Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Bayer Influenza Drugs and Vaccines Products Offered
10.10.5 Bayer Recent Development
10.11 Celgene
10.11.1 Celgene Company Information
10.11.2 Celgene Introduction and Business Overview
10.11.3 Celgene Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Celgene Influenza Drugs and Vaccines Products Offered
10.11.5 Celgene Recent Development
10.12 Seqirus
10.12.1 Seqirus Company Information
10.12.2 Seqirus Introduction and Business Overview
10.12.3 Seqirus Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Seqirus Influenza Drugs and Vaccines Products Offered
10.12.5 Seqirus Recent Development
10.13 Protein Sciences Corporation
10.13.1 Protein Sciences Corporation Company Information
10.13.2 Protein Sciences Corporation Introduction and Business Overview
10.13.3 Protein Sciences Corporation Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Protein Sciences Corporation Influenza Drugs and Vaccines Products Offered
10.13.5 Protein Sciences Corporation Recent Development
10.14 Serum Institute of India
10.14.1 Serum Institute of India Company Information
10.14.2 Serum Institute of India Introduction and Business Overview
10.14.3 Serum Institute of India Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Serum Institute of India Influenza Drugs and Vaccines Products Offered
10.14.5 Serum Institute of India Recent Development
10.15 Emergent Biosolutions
10.15.1 Emergent Biosolutions Company Information
10.15.2 Emergent Biosolutions Introduction and Business Overview
10.15.3 Emergent Biosolutions Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Emergent Biosolutions Influenza Drugs and Vaccines Products Offered
10.15.5 Emergent Biosolutions Recent Development
10.16 BioCryst Pharmaceuticals
10.16.1 BioCryst Pharmaceuticals Company Information
10.16.2 BioCryst Pharmaceuticals Introduction and Business Overview
10.16.3 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.16.4 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Products Offered
10.16.5 BioCryst Pharmaceuticals Recent Development
10.17 Alvogen
10.17.1 Alvogen Company Information
10.17.2 Alvogen Introduction and Business Overview
10.17.3 Alvogen Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Alvogen Influenza Drugs and Vaccines Products Offered
10.17.5 Alvogen Recent Development
10.18 Viatris
10.18.1 Viatris Company Information
10.18.2 Viatris Introduction and Business Overview
10.18.3 Viatris Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Viatris Influenza Drugs and Vaccines Products Offered
10.18.5 Viatris Recent Development
10.19 Hulan Bio
10.19.1 Hulan Bio Company Information
10.19.2 Hulan Bio Introduction and Business Overview
10.19.3 Hulan Bio Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Hulan Bio Influenza Drugs and Vaccines Products Offered
10.19.5 Hulan Bio Recent Development
10.20 Changchun Institute of Biological
10.20.1 Changchun Institute of Biological Company Information
10.20.2 Changchun Institute of Biological Introduction and Business Overview
10.20.3 Changchun Institute of Biological Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.20.4 Changchun Institute of Biological Influenza Drugs and Vaccines Products Offered
10.20.5 Changchun Institute of Biological Recent Development
10.21 Jiangsu GDK
10.21.1 Jiangsu GDK Company Information
10.21.2 Jiangsu GDK Introduction and Business Overview
10.21.3 Jiangsu GDK Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.21.4 Jiangsu GDK Influenza Drugs and Vaccines Products Offered
10.21.5 Jiangsu GDK Recent Development
10.22 Sinovac
10.22.1 Sinovac Company Information
10.22.2 Sinovac Introduction and Business Overview
10.22.3 Sinovac Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.22.4 Sinovac Influenza Drugs and Vaccines Products Offered
10.22.5 Sinovac Recent Development
10.23 Beike Bio
10.23.1 Beike Bio Company Information
10.23.2 Beike Bio Introduction and Business Overview
10.23.3 Beike Bio Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.23.4 Beike Bio Influenza Drugs and Vaccines Products Offered
10.23.5 Beike Bio Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Influenza Drugs and Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Influenza Drugs and Vaccines Industrial Chain Analysis
11.4 Influenza Drugs and Vaccines Market Dynamics
11.4.1 Influenza Drugs and Vaccines Industry Trends
11.4.2 Influenza Drugs and Vaccines Market Drivers
11.4.3 Influenza Drugs and Vaccines Market Challenges
11.4.4 Influenza Drugs and Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Influenza Drugs and Vaccines Distributors
12.3 Influenza Drugs and Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock